Why these All Ords shares have almost doubled in value this month

Unibail-Rodamco-Westfield CDI (ASX:URW) and these All Ords shares have almost doubled in value in November…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries index may be racing higher this month, but its 11% gain pales in comparison to some of the gains being made in November.

Three All Ords shares that have been on fire this month are listed below. Here's why they are rocketing higher:

Japara Healthcare Ltd (ASX: JHC)

The Japara Healthcare share price has surged 102% higher since the start of the month. Investors have been buying the aged care provider's shares in November despite there being no news out of the company. The catalyst for this gain appears to have been due to its rival, Regis Healthcare Ltd (ASX: REG), receiving a takeover offer from investment house Washington H. Soul Pattinson & Co Ltd (ASX: SOL). This led to sector wide upgrades being made by analysts at JP Morgan.

Telix Pharmaceuticals Ltd (ASX: TLX)

The Telix share price has been a very strong performer and is up an impressive 93% this month. Investors have been buying the nuclear medicine company's shares for a couple of reasons. One is the announcement of a strategic commercial partnership with China Grand Pharmaceutical and Healthcare Holdings. This agreement is for its portfolio of Molecularly-Targeted Radiation products. It includes a US$25 million up-front non-refundable prepayment to Telix and up to US$225 million in milestone payments. In addition to this, news that the US FDA has approved its new drug application for a prostate cancer imaging product went down well with the market.

Unibail-Rodamco-Westfield CDI (ASX: URW)

The Unibail Rodamco Westfield share price has jumped 75% since the start of the month. Investors have been fighting to get hold of the shopping centre operator's shares thanks to positive COVID-19 vaccine developments. A highly effective vaccine could give its struggling Westfield centres around the world a huge lift in 2021.

Motley Fool contributor James Mickleboro owns shares of TELIXPHARM DEF SET. The Motley Fool Australia owns shares of and has recommended Washington H. Soul Pattinson and Company Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »